Cost-effectiveness of measles and rubella elimination in low-income and middle-income countries

Cost-effectiveness of measles and rubella elimination in low-income and middle-income countries

Background Since 2000, the incidence of measles and rubella has declined as measles–rubella (MR) vaccine coverage increased due to intensified routine immunisation (RI) and supplementary immunisation activities (SIAs). The World Health Assembly commissioned a feasibility assessment of eliminating me...

Descrizione completa

Dettagli Bibliografici
Autori principali: Mark Jit, Emilia Vynnycky, Amy Winter, Kevin McCarthy, Ann Levin, Winthrop Morgan, Colleen Burgess, Stephanie Shendale, Raymond Cw Hutubessy, Brian Lambert, Heather Santos, Jennifer K Knapp, Lidia K Kayembe, Matthew Ferrari, Timos Papadopoulos
Natura: Articolo
Lingua:English
Pubblicazione: BMJ Publishing Group 2023-07-01
Serie:BMJ Global Health
Accesso online:https://gh.bmj.com/content/8/7/e011526.full

Accesso online

https://gh.bmj.com/content/8/7/e011526.full

Documenti analoghi